September 18th 2024
Your daily dose of the clinical news you may have missed.
September 17th 2024
New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.
September 13th 2024
Unawareness was highest among the youngest adults, aged 18 to 44 years, an age range where CV health should be optimized to avoid later morbidity, researchers wrote.
Approximately 10.5 million US adults, or 5% of the population, have the atrial fibrillation, according to new prevalence estimates.
September 12th 2024
Daily Dose: Subclinical CVD Affects 1 in 3 US Adults with Diabetes
Your daily dose of clinical news you may have missed.
Long COVID was Apparent by Summer 2020 and in a Wide Range of Patients
Symptoms of long COVID were apparent by the summer of 2020, said physiatrist Dr Leslie Rydberg, coauthor of new consensus guidelines on management of neurologic sequelae.
One in 3 US Adults with T2D Shows Evidence of Subclinical CVD Based on Cardiac Biomarkers
As indicated by levels of 2 common biomarkers of cardiac injury, 33.4% of US adults with T2D showed evidence of undetected CVD vs only 16.1% of those without T2D.
FDA Approves SGLT-2/1 Inhibitor Sotagliflozin, Grants Broad Heart Failure Indication
The novel co-inhibitor of sodium glucose cotransporter-1/2 proteins will be available by the end of June 2023, according to Lexicon Pharmaceuticals.
Comorbidities Associated with COPD Affect Outcomes, Require Attention
At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.
Asundexian Granted FDA Fast Track Designation for Stroke Prevention in Patients with AF
Bayer's investigational FXIa inhibitor is currently being studied in a large-scale phase 3 development program expected to enroll more than 27 000 participants.
Daily Dose: Global Deaths from Ischemic Stroke May Reach 5 Million by 2030
Statin Therapy May be Protective Against Stroke in People with Atrial Fibrillation: New Study
Statin therapy initiated within 1 year of diagnosis of atrial fibrillation reduced the risk of ischemic stroke or systemic embolism by nearly 20%.
Global Deaths from Ischemic Stroke May Reach 5 Million by 2030, According to New Study
Findings also showed that between 1990 and 2019, the global number of ischemic stroke deaths rose from 2 million to 3 million.
COPD Increases Risk for Heart Failure in People who Experience AMI
“Patients with COPD who have AMI are less aggressively treated than those without COPD," leading to higher in-hospital mortality and long-term mortality,” wrote authors.
FDA Grants Dapagliflozin Label Expansion for Treatment of Full Spectrum of Heart Failure
The label expansion is based on findings from the pivotal phase 3 DELIVER trial in which dapagliflozin reduced the composite CV/HF endpoint in HF patients with HFmrEF or HFpEF.
9 New Studies on Women's Health in Recognition of Women's Health Week 2023
Women's Health Week (May 14-20, 2023) is an ideal opportunity to review the top research, policy shifts, and potential drug approvals that affect your patient panel.
Daily Dose: Sex‐Specific Reproductive Factors Augment CVD Risk in Women
Reproductive Factors in Women Contribute to Risk of Cardiovascular Disease, According to New Study
Results of a Mendelian randomization study showed earlier first birth, higher number of live births, and earlier menarche are all associated with increased CVD.
Women Underrepresented in Late-breaking Cardiovascular Clinical Trials, a New Analysis Finds
Sex-based disparities found in high-profile clinical trials presented at 3 key cardiology scientific meetings underscore the lack of progress made toward equitable inclusion in research.
Is There a Vaccine to Help Reduce the Risk of Heart Attack?
Reducing American's risk for CHD and cardiovascular events gets harder as the population ages and obesity rates climb. Can a vaccine help?
Friday's 5 Quotes for Primary Care 5-5-2023
Tirzepatide delivers 15.7% weight loss in adults with obesity; remote intervention increases cancer screening in women; women at greater post-MI risk vs men; plus 2 more updates of note.
Daily Dose: Sex Difference in Outcomes of AMI in Young Adults
Young Women More Likely to be Rehospitalized after Acute Myocardial Infarction than Men
Young women who survived a myocardial infarction may have nearly double the risk of rehospitalization in the year after discharge compared to men, according to a new study.
ACP Announces Intensified Advocacy for Equitable Care of Obesity
The American College of Physicians announced an initiative that renews and expands its focus on equitable access to obesity care, including new resources for physicians.
Psychological Interventions for Depression Associated with Reduced CVD Risk in New Study
Researchers found that reliable improvement of depressive symptoms after psychological therapy was associated with a 12% decrease in CVD risk at any given time.
Daily Dose: Physician and Patient Perspectives on Oral Anticoagulation for AF
"Disconnect" on Oral Anticoagulation Observed Between Patients with AF and their Physicians
More than two-thirds of patients not receiving OAC were open to beginning treatment but many of their physicians were not, according to a study of PINNACLE Registry participants.
Metabolic Syndrome and Poor Fitness in Women Increase Long-term CVD Risk: New Research
Women with ischemic heart disease who were metabolically unhealthy but fit were more than 50% more likely to experience a major adverse cardiovascular event.
Beverage Choice May Help Reduce Mortality, CVD in Adults with Type 2 Diabetes, Findings Suggest
Higher intake of sugar-sweetened drinks was linked to increased risk of all-cause death and CVD while healthier choices were inversely associated with both, a new study found.
Friday's 5 Quotes for Primary Care 4-21-2023
Statins in AF patients cut risk of TIA; opioid makers must strengthen label warnings; individualized Rx reduces BP; and 2 more research quotes of note.
Daily Dose: Prenatal Depression & Risk of New CVD Postpartum
Daily Dose: Statin Effects in AF-related Stroke
Prenatal Depression Associated with New CVD Diagnosis Postpartum, According to New Data
Pregnant women with prenatal depression were found to be more likely to be diagnosed with new CVD within 2 years of delivery than those without depression.
Daily Dose: Meditation for Patients with Coronary Artery Disease